Clinical Trials on Mycobacterium Infections in United Kingdom

Total 20109 results

The University of Texas Health Science Center at...
Pfizer

Completed

Effectiveness of Rifabutin in the Treatment of Mycobacterium Avium Complex

Nontuberculous Mycobacterial Infections

United States
University of Illinois at Chicago

Terminated

Treatment Outcomes in Patient With Nontuberculous Mycobacterial Disease

Atypical Mycobacterium Infections | Nontuberculous Mycobacterial Disease

United States
St George's, University of London

Unknown

Innovative Reagents for Improving Rapid Diagnosis of Mycobacterial Infections (TIKA_TB)

Tuberculosis (TB)

United Kingdom
The University of Texas Health Science Center at...
Abbott

Completed

Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM)

Mycobacterium Avium Complex | Nontuberculous Mycobacteria

United States
Paratek Pharmaceuticals Inc

Active, not recruiting

Oral Omadacycline vs. Placebo in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc)

Mycobacterium Infections, Nontuberculous | Nontuberculous Mycobacterial Lung Disease | Mycobacterium Abscessus Infection | Nontuberculous Mycobacterial Pulmonary Infection

United States
University of Oxford

Completed

A Study to Determine the Safety and Immunogenicity of a Candidate MAP Vaccines ChAdOx2 HAV and MVA in Healthy Adult Volunteers

Crohn Disease | Mycobacterium Avium Subspecies Paratuberculosis

United Kingdom
National Institute of Allergy and Infectious Diseases...

Completed

Sildenafil for PNTM Infection

Nontuberculous Mycobacterial Infection

United States
Medical University of South Carolina
Oregon Health and Science University; Cystic Fibrosis Foundation

Completed

A Proof of Concept Study of Inhaled Nitric Oxide for Adults With Pulmonary Non-Tuberculous Mycobacterial Infection

Nontuberculous Mycobacterium Infection

United States
National Jewish Health

Recruiting

Transmission and Acquisition of Nontuberculous Mycobacteria Outbreak Investigation (TrANsMIt) (C)

Mycobacterium Infections | Healthcare Associated Infection | Nontuberculous Mycobacterial Pulmonary Infection | Outbreak Investigation

United States
Spero Therapeutics

Recruiting

A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SPR720 as Compared With Placebo for the Treatment of Participants With Mycobacterium Avium Complex (MAC) Pulmonary Disease

Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)

United States
Oregon Health and Science University
University Health Network, Toronto; New York University; NTM Info & Research,...

Recruiting

Hypertonic Saline for MAC

Nontuberculous Mycobacterial Lung Disease | Nontuberculous Mycobacterium Infection

United States, Canada
National Institutes of Health Clinical Center (CC)

Completed

Comparing Expectorated and Induced Sputum and Pharyngeal Swabs for Cultures, AFB Smears, and Cytokines in Pulmonary Nontuberculous Mycobacterial Infection

Mycobacterium Infections, Non-tuberculous

United States
Liverpool School of Tropical Medicine
University of Oxford

Recruiting

Using BCG Vaccine to Understand Tuberculosis Infection (Pilot BCG CHIM)

Tuberculosis

United Kingdom
National Institute of Allergy and Infectious Diseases...

Completed

Adjuvant Cytokine Therapy to Treat Pulmonary Mycobacterium Avium Complex Infection

Mycobacterium Avium-Intracellulare Infection

United States
The University of Texas Health Science Center at...
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Tigecycline for Treatment of Rapidly Growing Mycobacteria

Mycobacterium Abscessus Lung Disease | Rapidly Growing Mycobacterial Lung Disease

United States
University College, London
Public Health England

Completed

Predictive Values of Next Generation Interferon Gamma Release Assays for Latent Tuberculosis Infection (NextGen)

Tuberculosis

United Kingdom
Queen Mary University of London
University College, London; Public Health England

Completed

Completion and Acceptability of Treatment Across Primary Care and the commUnity for Latent Tuberculosis (CATAPULT)

Latent Tuberculosis

United Kingdom
Royal Brompton & Harefield NHS Foundation Trust
Heidelberg University; Chelsea and Westminster NHS Foundation Trust

Withdrawn

EBUS-TBNA Versus EBUS-TBNB

Lymphoma | Carcinoma | Sarcoidosis | Mediastinal Lymphadenopathy | Hilar Lymphadenopathy | Mycobacterial Disease

United Kingdom, Germany
Pfizer

Completed

An Open-Label Study of the Use of Azithromycin in Patients With Symptomatic Disseminated Mycobacterium Avium-Intracellulare Complex (MAC) Infection Failing Current Therapy

HIV Infections | Mycobacterium Avium-Intracellulare Infection

United States
Abbott
National Cancer Institute (NCI)

Completed

The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosine in the Treatment of Mycobacterium Avium Complex (MAC) Infections in Children With AIDS

HIV Infections | Mycobacterium Avium-intracellulare Infection

United States
University of California, San Francisco

Completed

A Randomized Controlled Prophylactic Study of Clofazimine To Prevent Mycobacterium Avium Complex Infection in HIV Disease

HIV Infections | Mycobacterium Avium-intracellulare Infection

United States
Amgen

Completed

Evaluation of the Therapeutic Benefit of r-metHuIFN- Gamma in AIDS Patients With Disseminated Mycobacterium Avium-Intracellulare (MAI) Infection: A Multi-Centered Pilot Study

HIV Infections | Mycobacterium Avium-Intracellulare Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Randomized, Double-Blinded, Placebo-Controlled, Phase II Inhaled Interferon Gamma-1b and Antimycobacterials to Treat Pulmonary Mycobacterium Avium Complex Infections

Mycobacterium Avium-Intracellulare Infection

United States
Kevin Winthrop
The University of Texas Health Science Center at Tyler; Insmed Incorporated

Completed

Liposomal Amikacin for Inhalation (LAI) in the Treatment of Mycobacterium Abscessus Lung Disease

Mycobacterium Infections, Nontuberculous | Mycobacteria, Atypical

United States
Aaron Diamond AIDS Research Center

Completed

Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV

HIV Infections | Mycobacterium Avium-Intracellulare Infection | Tuberculosis, Mycobacterium Infection

United States
Pfizer

Completed

A Study of Azithromycin in the Prevention of Mycobacterium Avium Complex Disease (MAC) in HIV-Infected Patients

HIV Infections | Mycobacterium Avium-Intracellulare Infection

United States
Queen Mary University of London
Imperial College London; University College, London; City, University of London

Active, not recruiting

Screening for Tuberculosis in Pregnancy (STOP)

Latent Tuberculosis

United Kingdom
BioMérieux

Completed

Performance Evaluation of the VIDAS TB-IGRA Assay.

Active Tuberculosis | Latent Tuberculosis Infection | Non-Tuberculous Mycobacterial (NTM) Pneumonia

United States, France, United Kingdom, India, Brazil, Georgia, Italy, Mexico, South Africa
The University of Queensland
University of Copenhagen; Erasmus Medical Center; Monash University; Hôpital Cochin and other collaborators

Recruiting

Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT)

Pulmonary Disease Due to Mycobacteria (Diagnosis)

Australia, Canada, Denmark, France, Ireland, Netherlands, New Zealand, United Kingdom, Singapore
Pfizer

Completed

A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy

HIV Infections | Mycobacterium Avium-Intracellulare Infection | Tuberculosis, Mycobacterium Infection

United States
Public Health England
Imperial College London; University College, London; Queen Mary University of... and other collaborators

Completed

Prognostic Value of Interferon Gamma Release Assays in Predicting Active Tuberculosis Among Individuals With, or at Risk of, Latent Tuberculosis Infection (PREDICT)

Latent Tuberculosis | Tuberculosis

United Kingdom
National Institute of Allergy and Infectious Diseases...
Abbott

Completed

A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. Avium Complex (MAC) Infections in Patients With AIDS

HIV Infections | Mycobacterium Avium-intracellulare Infection

United States
Kevin Winthrop
Patient-Centered Outcomes Research Institute; Medical University of South Carolina and other collaborators

Recruiting

Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease (MAC2v3)

Mycobacterium Avium Complex | Nontuberculous Mycobacterium Infection

United States, Canada
Pharmacia

Completed

A Study of Rifabutin, Used Alone or With Ethambutol in the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in Patients With AIDS

HIV Infections | Mycobacterium Avium-Intracellulare Infection

United States
Anderson Clinical Research
Hoechst Marion Roussel

Completed

Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia.

HIV Infections | Mycobacterium Avium-Intracellulare Infection

United States
Johns Hopkins University

Recruiting

A Study of Standard Drugs for Mycobacterium Avium Complex

Mycobacterium Avium Complex

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.

HIV Infections | Mycobacterium Avium-intracellulare Infection

United States
Pharmacia

Completed

Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND Study

HIV Infections | Mycobacterium Avium-intracellulare Infection

United States
Synspira, Inc.

Terminated

A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis

Lung Diseases | Cystic Fibrosis | Pulmonary Disease | Antibiotic Resistant Infection | Respiratory Tract Disease | Cystic Fibrosis Pulmonary Exacerbation | Lung Inflammation | Burkholderia Infections | Lung Infection | Multi-antibiotic Resistance | Pulmonary Inflammation | Lung Infection Pseudomonal | Cystic Fibrosis... and other conditions

United Kingdom
Agouron Pharmaceuticals

Completed

A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC)

HIV Infections | Mycobacterium Avium-Intracellulare Infection

United States
Pfizer

Completed

A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients

HIV Infections | Mycoses | Mycobacterium Avium-Intracellulare Infection

United States
Abbott

Completed

The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients

HIV Infections | Mycobacterium Avium-intracellular Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Study to Examine the Effects of Stopping Preventive Therapy for Disseminated Mycobacterium Avium Complex (DMAC) in HIV-Positive Patients

HIV Infections | Mycobacterium Avium-Intracellulare Infection

United States
Pfizer

Completed

A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients

HIV Infections | Mycobacterium Avium-intracellulare Infection

United States
Abbott

Completed

The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDS

HIV Infections | Mycobacterium Avium-intracellular Infection

United States, Puerto Rico
National Institute of Allergy and Infectious Diseases...

Completed

A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS

HIV Infections | Mycobacterium Avium-intracellulare Infection

United States, Tanzania
National Institute of Allergy and Infectious Diseases...

Completed

Evaluation of Treatment for Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients

HIV Infections | Mycobacterium Avium-intracellulare Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients

HIV Infections | Mycobacterium Avium-intracellulare Infection

United States, Tanzania
National Institute of Allergy and Infectious Diseases...

Completed

The Effects of Treatment for Mycobacterium Avium Complex (MAC) on the Cells of HIV-Infected Patients

HIV Infections | Mycobacterium Avium-Intracellulare Infection

United States
Oregon Health and Science University
National Institute of Allergy and Infectious Diseases (NIAID); National Heart... and other collaborators

Recruiting

Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC)

Mycobacterium Avium Complex

United States

Clinical Trials on Mycobacterium Infections in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations